{"AllianceGenome": "9567", "HGNC": "9567", "MIM": "603146", "_id": "5715", "_version": 2, "accession": {"genomic": ["AC069503.25", "CH471054.1", "CP068266.2", "CQ840923.1", "FB353533.1", "KF459562.1", "KT584980.1", "NC_000012.12", "NC_060936.1"], "protein": ["AAH02383.1", "AAH04184.1", "AAH04213.1", "BAG37782.1", "CAH05702.1", "CAR82351.1", "EAW98293.1", "EAW98294.1", "EAW98295.1", "EAW98296.1", "EAW98297.1", "NP_001248329.1", "NP_002804.2", "O00233.3"], "rna": ["AK055339.1", "AK315389.1", "BC002383.2", "BC004184.2", "BC004213.2", "BI832046.1", "BM850893.1", "BU726372.1", "BU956605.1", "CB111716.1", "CN260241.1", "NM_001261400.3", "NM_002813.7", "NR_048555.3"], "translation": [{"protein": "AAH04213.1", "rna": "BC004213.2"}, {"protein": "NP_002804.2", "rna": "NM_002813.7"}, {"protein": "AAH04184.1", "rna": "BC004184.2"}, {"protein": "AAH02383.1", "rna": "BC002383.2"}, {"protein": "BAG37782.1", "rna": "AK315389.1"}, {"protein": "NP_001248329.1", "rna": "NM_001261400.3"}]}, "alias": ["Rpn4", "p27"], "ensembl": {"gene": "ENSG00000110801", "protein": ["ENSP00000261817", "ENSP00000440485", "ENSP00000440500", "ENSP00000442210", "ENSP00000443081", "ENSP00000443772", "ENSP00000443968", "ENSP00000445058"], "transcript": ["ENST00000261817", "ENST00000361485", "ENST00000535293", "ENST00000537407", "ENST00000538613", "ENST00000540962", "ENST00000541212", "ENST00000542602", "ENST00000543699", "ENST00000544254", "ENST00000544724"], "translation": [{"protein": "ENSP00000445058", "rna": "ENST00000537407"}, {"protein": "ENSP00000442210", "rna": "ENST00000540962"}, {"protein": "ENSP00000261817", "rna": "ENST00000261817"}, {"protein": "ENSP00000443081", "rna": "ENST00000538613"}, {"protein": "ENSP00000443772", "rna": "ENST00000542602"}, {"protein": "ENSP00000440485", "rna": "ENST00000541212"}, {"protein": "ENSP00000440500", "rna": "ENST00000543699"}, {"protein": "ENSP00000443968", "rna": "ENST00000535293"}], "type_of_gene": "protein_coding"}, "entrezgene": "5715", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 7.51180615872, "exp_mis": 85.1191337023, "exp_syn": 40.388196467, "lof_z": 0.184979250186253, "mis_z": 0.112346735029201, "mu_lof": 5.82372430542e-07, "mu_mis": 8.94964600138e-06, "mu_syn": 4.22692580135e-06, "n_lof": 7.0, "n_mis": 83.0, "n_syn": 30.0, "p_li": 3.77628232193741e-05, "p_null": 0.622449321723498, "p_rec": 0.377512915453283, "syn_z": 1.01335703558371}, "bp": 672, "cds_end": 122354217, "cds_start": 122326762, "n_exons": 6, "nonpsych": {"exp_lof": 6.69135793173, "exp_mis": 76.9334805662, "exp_syn": 36.4476625736, "lof_z": -0.117179037682298, "mis_z": -0.00382521841321098, "mu_lof": 5.82372430542e-07, "mu_mis": 8.94964600138e-06, "mu_syn": 4.22692580135e-06, "n_lof": 7.0, "n_mis": 77.0, "n_syn": 27.0, "p_li": 2.36057917115352e-05, "p_null": 0.719937309254494, "p_rec": 0.280039084953794, "syn_z": 0.985264702074772}, "nontcga": {"exp_lof": 6.90037839043, "exp_mis": 78.2991252242, "exp_syn": 37.1466576697, "lof_z": 0.338119230853914, "mis_z": 0.0168416366386937, "mu_lof": 5.82372430542e-07, "mu_mis": 8.94964600138e-06, "mu_syn": 4.22692580135e-06, "n_lof": 6.0, "n_mis": 78.0, "n_syn": 27.0, "p_li": 0.000215803073988999, "p_null": 0.499351833490981, "p_rec": 0.50043236343503, "syn_z": 1.05410903990634}, "transcript": "ENST00000541212.1"}, "exons": [{"cdsend": 121916311, "cdsstart": 121888856, "chr": "12", "position": [[121888789, 121888994], [121903005, 121903107], [121915855, 121915944], [121916283, 121918297]], "strand": 1, "transcript": "NM_001261400", "txend": 121918297, "txstart": 121888789}, {"cdsend": 121916311, "cdsstart": 121888856, "chr": "12", "position": [[121888789, 121888994], [121894738, 121894841], [121899633, 121899845], [121903005, 121903107], [121915855, 121915944], [121916283, 121918297]], "strand": 1, "transcript": "NM_002813", "txend": 121918297, "txstart": 121888789}, {"cdsend": 121918297, "cdsstart": 121918297, "chr": "12", "position": [[121888789, 121888994], [121894738, 121894841], [121903005, 121903107], [121915855, 121915944], [121916283, 121918297]], "strand": 1, "transcript": "NR_048555", "txend": 121918297, "txstart": 121888789}], "exons_hg19": [{"cdsend": 122354217, "cdsstart": 122326762, "chr": "12", "position": [[122326695, 122326900], [122340911, 122341013], [122353761, 122353850], [122354189, 122356203]], "strand": 1, "transcript": "NM_001261400", "txend": 122356203, "txstart": 122326695}, {"cdsend": 122354217, "cdsstart": 122326762, "chr": "12", "position": [[122326695, 122326900], [122332644, 122332747], [122337539, 122337751], [122340911, 122341013], [122353761, 122353850], [122354189, 122356203]], "strand": 1, "transcript": "NM_002813", "txend": 122356203, "txstart": 122326695}, {"cdsend": 122356203, "cdsstart": 122356203, "chr": "12", "position": [[122326695, 122326900], [122332644, 122332747], [122340911, 122341013], [122353761, 122353850], [122354189, 122356203]], "strand": 1, "transcript": "NR_048555", "txend": 122356203, "txstart": 122326695}], "generif": [{"pubmed": 12778072, "text": "Presence is associated with high nuclear grade, large tumor size, and poor prognosis for glioma patients."}, {"pubmed": 17360176, "text": "The researchers found evidence of increased positive identification of p27 following neoadjuvant therapy in colorectal cancer patients, p27 was a good predictor of FR in the pre-radiation biopsy, and p27(+) markers in specimens lived longer at 3 years."}, {"pubmed": 17516568, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17516568, "text": "PSMD9 gene variants contribute rarely to late-onset type 2 diabetes in Italians."}, {"pubmed": 18504423, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18694622, "text": "Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer."}, {"pubmed": 18701138, "text": "We report a direct correlation between cyclin D3 and p27 expression in gastrointestinal stromal tumors."}, {"pubmed": 19041685, "text": "Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting p27 level."}, {"pubmed": 19118035, "text": "In RCC, p27 is phosphorylated at T157 of the NLS, with increasing tumor grade associated with cytoplasmic p27."}, {"pubmed": 19657726, "text": "The expression of p53 and p27 was not related to HPV genotype in cervical carcinomas"}, {"pubmed": 19877155, "text": "PSMD9 gene in the NIDDM2 locus is linked to type 2 diabetes in Italians."}, {"pubmed": 20069546, "text": "Show that the MODY3 mutation and the PSMD9 IVS3 + nt460A/IVS3 + nt437T/G197 SNPs are risk factors for type 2 diabetes in Italian families."}, {"pubmed": 20878082, "text": "Cul1 regulates melanoma cell growth and cell cycle progression through degradation of p27"}, {"pubmed": 21439668, "text": "Data show that the PSMD9 IVS3 + nt460, IVS3 + nt437, E197G T2D risk SNPs are in linkage with diabetic nephropathy."}, {"pubmed": 21448710, "text": "This study is the first to demonstrate the expression of Bridge-1 in human breast carcinomas. Bridge-1 expression is increased by activin A stimulation and itself seems to influence activin A signaling by affecting the expression of Smad2, 3 and 4."}, {"pubmed": 21477582, "text": "Analysis of Gem-resistant sub lines also showed that loss of UBE2M and increased p27(Kip1) expression were associated with the acquisition of drug resistance."}, {"pubmed": 21496327, "text": "PSMD9 IVS3+nt460A/G, +nt437C/T and exon E197G A/G SNPs are linked to coronary artery disease, stroke/TIA and macrovascular pathology of type 2 diabetes in Italians."}, {"pubmed": 21554682, "text": "PSMD9 SNPs IVS3 + nt460 A >G, IVS3 + nt437 C > T and E197G A > G are linked to the hypercholesterolemia phenotype in Italian type 2 diabetes families."}, {"pubmed": 21728808, "text": "In summary, the PSMD9 IVS3+nt460, IVS3+nt437, E197G SNPs are linked to diabetic retinopathy and non-diabetic retinopathy in Italians."}, {"pubmed": 21813292, "text": "genetic association studies in a population in Italy: SNPs in PSMD9 are strongly linked to diabetic neuropathy in subjects with type 2 diabetes; these associations show significance for an additive model-based inheritance."}, {"pubmed": 21837501, "text": "overexpression of Jab1, cytoplasmic p27, and pSer10p27 proteins is correlated with poor outcome in patients with glioma"}, {"pubmed": 21862167, "text": "Brief Report: PSMD9 SNPs show linkage to carpal tunnel syndrome in Italian type 2 diabetics."}, {"pubmed": 21871126, "text": "PSMD9 gene SNPs are linked to elevated blood pressure/hypertension in Italian families with type 2 diabetes."}, {"pubmed": 22015693, "text": "the PSMD9 IVS3 + nt460, IVS3 + nt437, E197G SNPs are linked via the recessive model to microvascular pathology of type 2 diabetes (T2D) in Italians"}, {"pubmed": 22934761, "text": "PSMD9 IVS3+nt460 A>G and +nt437 C>T and exon 5 E197G A>G single nucleotide polymorphisms studied and/or any variants in linkage disequilibrium with them are linked to depression in our type 2 diabetes Italian families."}, {"pubmed": 23282078, "text": "The PSMD9 single nucleotide polymorphism(SNP)s IVS3+nt460, IVS3+nt437, and 197G are in linkage with overweight condition and waist circumference in Italians."}, {"pubmed": 23464457, "text": "Expression of Hath1, Muc2, cyclin D1 and p27 in the xenograft tumors was also detected."}, {"pubmed": 23618860, "text": "Surprisingly, we found that GRP/GRP-R differentially induced expressions of p21 and p27. Silencing GRP/GRP-R decreased p21, but it increased p27 expressions in neuroblastoma cells."}, {"pubmed": 23689538, "text": "Our results suggest that tuberin and p27 are aberrantly expressed in malignant breast tissue"}, {"pubmed": 24648162, "text": "Describe PSMD9 gene SNPs in linkage to generalized anxiety disorder in type 2 diabetic families."}, {"pubmed": 24673853, "text": "PSMD9 expression predicts radiotherapy response in breast cancer."}, {"pubmed": 24852133, "text": "Staining intensities of cell cycle inhibitors p27 and p57 significantly increased in all parts of preeclamptic placentas compared to control"}, {"pubmed": 25545366, "text": "The present study provided the first evidences that miR-1470 mediated lapatinib induced p27 upregulation by targeting c-jun."}, {"pubmed": 26166263, "text": "The PSMD9 intronic SNPs rs74421874 (IVS3+nt460 G>A) and rs3825172 (IVS3+nt437 C>T) remain significantly associated with insomnia only when taking into account anxiety -and not depression- as covariate."}, {"pubmed": 26191286, "text": "recurrence rate of p27 and/or PTEN-negative patients was higher than that of the positive ones,that should be followed up closely after treatment"}, {"pubmed": 26447892, "text": "p53 immunopositivity was more frequent in SCC (65%) than in VC (23%) (P</=0.001). VC had lower p53 as compared with well-differentiated SCC and SCC without lymph node metastasis. No significant difference was seen in pRb, p16, and p27 expression"}, {"pubmed": 26624926, "text": "Studies have found significant associations of the treatment response with the 26S proteasome non-ATPase subunit 9 (PSMD9), proteasome alpha type 7 subunit (PSMA7) and PSMD13 genes."}, {"pubmed": 26917264, "text": "Loss of p27 associated with risk for endometrial carcinoma arising in the setting of obesity."}, {"pubmed": 28325896, "text": "These data suggest that Schistosoma japonicum Sjp40 might inhibit hepatic stellate cell activation by promoting cellular senescence via SKP2/P27 signaling pathway."}, {"pubmed": 28650473, "text": "human epidermal growth factor receptor 2 (HER-2) levels, were correlated well with TSP50/p-Samd2/3 and TSP50/p27 expression status. Thus, our studies revealed a novel regulatory mechanism underlying TSP50-induced cell proliferation and provided a new favorable intervention target for the treatment of breast cancer"}, {"pubmed": 28919423, "text": "Furthermore, inhibition of COPS5 resulted in an elevation of Akt expression and sensitized SOC cells to Akt inhibitor MK2206. Suppression of COPS5 and Akt offers a potential strategy for the treatment of SOC."}, {"pubmed": 31180541, "text": "Molecular experiments showed that miR2213p was able to bind with the 3'untranslated region (UTR) of p27 and decreased the expression of p27 in nonsmall cell lung cancer cells."}, {"pubmed": 31287951, "text": "Novel Determinant of PSMD9 PDZ Binding"}, {"pubmed": 32356429, "text": "Proteasome modulator 9 (PSMD9) gene rs14259 polymorphism in Alzheimer's disease."}, {"pubmed": 33589597, "text": "UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development."}, {"pubmed": 34077860, "text": "PSMD9 ribosomal protein network maintains nucleolar architecture and WT p53 levels."}, {"pubmed": 35439960, "text": "KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27(Kip1) pathway."}, {"pubmed": 36524506, "text": "PSMD9 is linked to T2D age of onset, years of isolated and combined insulin therapy, irregular menses, and hot flashes."}, {"pubmed": 37485655, "text": "Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma."}, {"pubmed": 37665644, "text": "The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis."}, {"pubmed": 38745188, "text": "PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling."}], "genomic_pos": {"chr": "12", "end": 121918297, "ensemblgene": "ENSG00000110801", "start": 121888732, "strand": 1}, "genomic_pos_hg19": {"chr": "12", "end": 122356203, "start": 122326637, "strand": 1}, "go": {"BP": [{"evidence": "NAS", "gocategory": "BP", "id": "GO:0006511", "pubmed": 9653651, "qualifier": "involved_in", "term": "ubiquitin-dependent protein catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032024", "pubmed": 10567574, "qualifier": "involved_in", "term": "positive regulation of insulin secretion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045893", "pubmed": [10567574, 16293776], "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0046676", "pubmed": 16099819, "qualifier": "involved_in", "term": "negative regulation of insulin secretion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0070682", "qualifier": "involved_in", "term": "proteasome regulatory particle assembly"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0070682", "pubmed": 19490896, "qualifier": "involved_in", "term": "proteasome regulatory particle assembly"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 10567574, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005838", "pubmed": 9653651, "qualifier": "part_of", "term": "proteasome regulatory particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0008540", "pubmed": 19490896, "qualifier": "part_of", "term": "proteasome regulatory particle, base subcomplex"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0003713", "pubmed": 10567574, "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16189514, 19490896, 21516116, 25009770, 25416956, 31515488, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0043425", "pubmed": 10567574, "qualifier": "enables", "term": "bHLH transcription factor binding"}]}, "homologene": {"genes": [[3702, 835906], [4530, 4347083], [4896, 2543070], [4932, 854810], [5141, 5847072], [7227, 41672], [7955, 436709], [8364, 549313], [9031, 416853], [9544, 701174], [9598, 465187], [9606, 5715], [9615, 477467], [9913, 513315], [10090, 67151], [10116, 161475], [28985, 2893277], [33169, 4620232], [318829, 2680923]], "id": 2106}, "interpro": [{"desc": "PDZ domain", "id": "IPR001478", "short_desc": "PDZ"}, {"desc": "26S Proteasome non-ATPase regulatory subunit 9", "id": "IPR035269", "short_desc": "PSMD9"}, {"desc": "PDZ superfamily", "id": "IPR036034", "short_desc": "PDZ_sf"}, {"desc": "Nas2, N-terminal", "id": "IPR040815", "short_desc": "Nas2_N"}, {"desc": "PDZ domain 6", "id": "IPR041489", "short_desc": "PDZ_6"}], "ipi": ["IPI00010860", "IPI00216220", "IPI00791380", "IPI01013039", "IPI01013452", "IPI01013622", "IPI01014017"], "map_location": "12q24.31", "name": "proteasome 26S subunit, non-ATPase 9", "other_names": ["26S proteasome non-ATPase regulatory subunit 9", "26S proteasome regulatory subunit p27", "homolog of rat Bridge 1", "proteasome (prosome, macropain) 26S subunit, non-ATPase, 9", "proteasome 26S non-ATPase regulatory subunit 9"], "pantherdb": {"HGNC": "9567", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1914401", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 10090, "uniprot_kb": "Q9CR00"}, {"RGD": "621110", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 10116, "uniprot_kb": "Q9WTV5"}, {"Ensembl": "ENSGALG00000004352", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 9031, "uniprot_kb": "F1NVH4"}, {"ZFIN": "ZDB-GENE-030131-431", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 7955, "uniprot_kb": "F1R7L1"}, {"WormBase": "WBGene00016623", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 6239, "uniprot_kb": "Q10920"}, {"FlyBase": "FBgn0038166", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 7227, "uniprot_kb": "Q9VFS8"}, {"SGD": "S000001269", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 4932, "uniprot_kb": "P40555"}, {"PomBase": "SPAC2H10.02c", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 4896, "uniprot_kb": "O94393"}, {"dictyBase": "DDB_G0275753", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 352472, "uniprot_kb": "Q552Y8"}, {"EnsemblGenome": "AT5G57950", "ortholog_type": "LDO", "panther_family": "PTHR12651", "taxid": 3702, "uniprot_kb": "A0A1P8BA81"}], "uniprot_kb": "O00233"}, "pathway": {"kegg": [{"id": "hsa03050", "name": "Proteasome - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05012", "name": "Parkinson disease - Homo sapiens (human)"}, {"id": "hsa05014", "name": "Amyotrophic lateral sclerosis - Homo sapiens (human)"}, {"id": "hsa05016", "name": "Huntington disease - Homo sapiens (human)"}, {"id": "hsa05017", "name": "Spinocerebellar ataxia - Homo sapiens (human)"}, {"id": "hsa05020", "name": "Prion disease - Homo sapiens (human)"}, {"id": "hsa05022", "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-109581", "name": "Apoptosis"}, {"id": "R-HSA-1168372", "name": "Downstream signaling events of B Cell Receptor (BCR)"}, {"id": "R-HSA-1169091", "name": "Activation of NF-kappaB in B cells"}, {"id": "R-HSA-1234174", "name": "Cellular response to hypoxia"}, {"id": "R-HSA-1234176", "name": "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"}, {"id": "R-HSA-1236974", "name": "ER-Phagosome pathway"}, {"id": "R-HSA-1236975", "name": "Antigen processing-Cross presentation"}, {"id": "R-HSA-1236975", "name": "Antigen processing-Cross presentation"}, {"id": "R-HSA-1236978", "name": "Cross-presentation of soluble exogenous antigens (endosomes)"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-157118", "name": "Signaling by NOTCH"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162906", "name": "HIV Infection"}, {"id": "R-HSA-162909", "name": "Host Interactions of HIV factors"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-169911", "name": "Regulation of Apoptosis"}, {"id": "R-HSA-174084", "name": "Autodegradation of Cdh1 by Cdh1:APC/C"}, {"id": "R-HSA-174113", "name": "SCF-beta-TrCP mediated degradation of Emi1"}, {"id": "R-HSA-174143", "name": "APC/C-mediated degradation of cell cycle proteins"}, {"id": "R-HSA-174154", "name": "APC/C:Cdc20 mediated degradation of Securin"}, {"id": "R-HSA-174178", "name": "APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"}, {"id": "R-HSA-174184", "name": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A"}, {"id": "R-HSA-176408", "name": "Regulation of APC/C activators between G1/S and early anaphase"}, {"id": "R-HSA-176409", "name": "APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-176814", "name": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-179419", "name": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"}, {"id": "R-HSA-180534", "name": "Vpu mediated degradation of CD4"}, {"id": "R-HSA-180585", "name": "Vif-mediated degradation of APOBEC3G"}, {"id": "R-HSA-187577", "name": "SCF(Skp2)-mediated degradation of p27/p21"}, {"id": "R-HSA-195253", "name": "Degradation of beta-catenin by the destruction complex"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-202403", "name": "TCR signaling"}, {"id": "R-HSA-202424", "name": "Downstream TCR signaling"}, {"id": "R-HSA-211733", "name": "Regulation of activated PAK-2p34 by proteasome mediated degradation"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-2454202", "name": "Fc epsilon receptor (FCERI) signaling"}, {"id": "R-HSA-2467813", "name": "Separation of Sister Chromatids"}, {"id": "R-HSA-2555396", "name": "Mitotic Metaphase and Anaphase"}, {"id": "R-HSA-2871837", "name": "FCERI mediated NF-kB activation"}, {"id": "R-HSA-349425", "name": "Autodegradation of the E3 ubiquitin ligase COP1"}, {"id": "R-HSA-350562", "name": "Regulation of ornithine decarboxylase (ODC)"}, {"id": "R-HSA-351202", "name": "Metabolism of polyamines"}, {"id": "R-HSA-376176", "name": "Signaling by ROBO receptors"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-382556", "name": "ABC-family proteins mediated transport"}, {"id": "R-HSA-3858494", "name": "Beta-catenin independent WNT signaling"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4086400", "name": "PCP/CE pathway"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-446652", "name": "Interleukin-1 family signaling"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-450408", "name": "AUF1 (hnRNP D0) binds and destabilizes mRNA"}, {"id": "R-HSA-450531", "name": "Regulation of mRNA stability by proteins that bind AU-rich elements"}, {"id": "R-HSA-453274", "name": "Mitotic G2-G2/M phases"}, {"id": "R-HSA-453276", "name": "Regulation of mitotic cell cycle"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-4608870", "name": "Asymmetric localization of PCP proteins"}, {"id": "R-HSA-4641257", "name": "Degradation of AXIN"}, {"id": "R-HSA-4641258", "name": "Degradation of DVL"}, {"id": "R-HSA-5357801", "name": "Programmed Cell Death"}, {"id": "R-HSA-5358346", "name": "Hedgehog ligand biogenesis"}, {"id": "R-HSA-5358351", "name": "Signaling by Hedgehog"}, {"id": "R-HSA-5358351", "name": "Signaling by Hedgehog"}, {"id": "R-HSA-5362768", "name": "Hh mutants are degraded by ERAD"}, {"id": "R-HSA-5387390", "name": "Hh mutants abrogate ligand secretion"}, {"id": "R-HSA-5607761", "name": "Dectin-1 mediated noncanonical NF-kB signaling"}, {"id": "R-HSA-5607764", "name": "CLEC7A (Dectin-1) signaling"}, {"id": "R-HSA-5610780", "name": "Degradation of GLI1 by the proteasome"}, {"id": "R-HSA-5610783", "name": "Degradation of GLI2 by the proteasome"}, {"id": "R-HSA-5610785", "name": "GLI3 is processed to GLI3R by the proteasome"}, {"id": "R-HSA-5610787", "name": "Hedgehog 'off' state"}, {"id": "R-HSA-5610787", "name": "Hedgehog 'off' state"}, {"id": "R-HSA-5619084", "name": "ABC transporter disorders"}, {"id": "R-HSA-5619115", "name": "Disorders of transmembrane transporters"}, {"id": "R-HSA-5621481", "name": "C-type lectin receptors (CLRs)"}, {"id": "R-HSA-5632684", "name": "Hedgehog 'on' state"}, {"id": "R-HSA-5658442", "name": "Regulation of RAS by GAPs"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-5668541", "name": "TNFR2 non-canonical NF-kB pathway"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5676590", "name": "NIK-->noncanonical NF-kB signaling"}, {"id": "R-HSA-5678895", "name": "Defective CFTR causes cystic fibrosis"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-5687128", "name": "MAPK6/MAPK4 signaling"}, {"id": "R-HSA-5688426", "name": "Deubiquitination"}, {"id": "R-HSA-5689603", "name": "UCH proteinases"}, {"id": "R-HSA-5689880", "name": "Ub-specific processing proteases"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-6807070", "name": "PTEN Regulation"}, {"id": "R-HSA-68867", "name": "Assembly of the pre-replicative complex"}, {"id": "R-HSA-68882", "name": "Mitotic Anaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-68949", "name": "Orc1 removal from chromatin"}, {"id": "R-HSA-69002", "name": "DNA Replication Pre-Initiation"}, {"id": "R-HSA-69017", "name": "CDK-mediated phosphorylation and removal of Cdc6"}, {"id": "R-HSA-69052", "name": "Switching of origins to a post-replicative state"}, {"id": "R-HSA-69202", "name": "Cyclin E associated events during G1/S transition "}, {"id": "R-HSA-69206", "name": "G1/S Transition"}, {"id": "R-HSA-69239", "name": "Synthesis of DNA"}, {"id": "R-HSA-69242", "name": "S Phase"}, {"id": "R-HSA-69275", "name": "G2/M Transition"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69306", "name": "DNA Replication"}, {"id": "R-HSA-69481", "name": "G2/M Checkpoints"}, {"id": "R-HSA-69541", "name": "Stabilization of p53"}, {"id": "R-HSA-69563", "name": "p53-Dependent G1 DNA Damage Response"}, {"id": "R-HSA-69580", "name": "p53-Dependent G1/S DNA damage checkpoint"}, {"id": "R-HSA-69601", "name": "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"}, {"id": "R-HSA-69610", "name": "p53-Independent DNA Damage Response"}, {"id": "R-HSA-69613", "name": "p53-Independent G1/S DNA damage checkpoint"}, {"id": "R-HSA-69615", "name": "G1/S DNA Damage Checkpoints"}, {"id": "R-HSA-69620", "name": "Cell Cycle Checkpoints"}, {"id": "R-HSA-69656", "name": "Cyclin A:Cdk2-associated events at S phase entry"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-75815", "name": "Ubiquitin-dependent degradation of Cyclin D"}, {"id": "R-HSA-8852276", "name": "The role of GTSE1 in G2/M progression after G2 checkpoint"}, {"id": "R-HSA-8854050", "name": "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis"}, {"id": "R-HSA-8878159", "name": "Transcriptional regulation by RUNX3"}, {"id": "R-HSA-8878166", "name": "Transcriptional regulation by RUNX2"}, {"id": "R-HSA-8878166", "name": "Transcriptional regulation by RUNX2"}, {"id": "R-HSA-8878171", "name": "Transcriptional regulation by RUNX1"}, {"id": "R-HSA-8939236", "name": "RUNX1 regulates transcription of genes involved in differentiation of HSCs"}, {"id": "R-HSA-8939902", "name": "Regulation of RUNX2 expression and activity"}, {"id": "R-HSA-8939902", "name": "Regulation of RUNX2 expression and activity"}, {"id": "R-HSA-8941858", "name": "Regulation of RUNX3 expression and activity"}, {"id": "R-HSA-8948751", "name": "Regulation of PTEN stability and activity"}, {"id": "R-HSA-8951664", "name": "Neddylation"}, {"id": "R-HSA-8953854", "name": "Metabolism of RNA"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9010553", "name": "Regulation of expression of SLITs and ROBOs"}, {"id": "R-HSA-9013694", "name": "Signaling by NOTCH4"}, {"id": "R-HSA-9020702", "name": "Interleukin-1 signaling"}, {"id": "R-HSA-9604323", "name": "Negative regulation of NOTCH4 signaling"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9711123", "name": "Cellular response to chemical stress"}, {"id": "R-HSA-9755511", "name": "KEAP1-NFE2L2 pathway"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9759194", "name": "Nuclear events mediated by NFE2L2"}, {"id": "R-HSA-9762114", "name": "GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2"}, {"id": "R-HSA-9793380", "name": "Formation of paraxial mesoderm"}, {"id": "R-HSA-9824272", "name": "Somitogenesis"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-983168", "name": "Antigen processing: Ubiquitination & Proteasome degradation"}, {"id": "R-HSA-983169", "name": "Class I MHC mediated antigen processing & presentation"}, {"id": "R-HSA-983169", "name": "Class I MHC mediated antigen processing & presentation"}, {"id": "R-HSA-983705", "name": "Signaling by the B Cell Receptor (BCR)"}], "wikipathways": [{"id": "WP183", "name": "Proteasome Degradation"}, {"id": "WP2359", "name": "Parkin-Ubiquitin Proteasomal System pathway"}]}, "pfam": ["PF17820", "PF18265"], "pharmgkb": "PA33913", "pharos": {"target_id": 13676, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF168301", "relationship": "is"}, {"id": "GNF179207", "relationship": "is"}, {"id": "GNF190113", "relationship": "is"}, {"id": "GNF201019", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF164508", "relationship": "weakly similar to"}, "GNF_hs-Origene": {"id": "GNF032977", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF030178", "relationship": "is"}, {"id": "GNF131359", "relationship": "is"}, {"id": "GNF131373", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF102793", "relationship": "is"}, {"id": "GNF142447", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1"], "protein": ["NP_001248329.1", "NP_002804.2"], "rna": ["NM_001261400.3", "NM_002813.7", "NR_048555.3"], "translation": [{"protein": "NP_002804.2", "rna": "NM_002813.7"}, {"protein": "NP_001248329.1", "rna": "NM_001261400.3"}]}, "reporter": {"HG-U133_Plus_2": ["207805_s_at", "209334_s_at"], "HG-U95Av2": ["1444_at", "36492_at"], "HTA-2_0": "TC12003259.hg.1", "HuEx-1_0": ["3435050", "3435074", "3435076"], "HuGene-1_1": "7959322", "HuGene-2_1": "16758186"}, "summary": "The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a non-ATPase subunit of the 19S regulator. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2012].", "symbol": "PSMD9", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419040"}, "unigene": "Hs.131151", "uniprot": {"Swiss-Prot": "O00233", "TrEMBL": ["F5GX23", "F5H7X1", "F5H5V4", "F5H169", "J3KN29"]}, "wikipedia": {"url_stub": "PSMD9"}}